Bvf Partners L P Xoma Corp (XOMA) insider trading activity

XOMA Quotes by TradingView

Bvf Partners L P is Director of XOMA Corp. Currently has a direct ownership of 1.62 Million shares of XOMA, which is worth approximately $48.3 Million. The most recent transaction as insider was on Jan 06, 2023, when has been sold 3,249 shares (Common Stock, $0.0075 par value per share) at a price of $21.98 per share, resulting in proceeds of $71,413. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.62M
0% 3M change
0% 12M change
Total Value Held $48.3 Million

BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2023
BUY
Open market or private purchase
$71,413 $21.98 p/Share
3,249 Added 0.2%
1,618,637 Common Stock, $0.0075 ...
Jan 05 2023
BUY
Open market or private purchase
$349,410 $18.39 p/Share
19,000 Added 1.16%
1,617,064 Common Stock, $0.0075 ...
Sep 27 2022
BUY
Open market or private purchase
$28,409 $16.89 p/Share
1,682 Added 0.1%
1,601,394 Common Stock, $0.0075 ...
Sep 26 2022
BUY
Open market or private purchase
$107,039 $16.83 p/Share
6,360 Added 0.4%
1,600,716 Common Stock, $0.0075 ...
Sep 23 2022
BUY
Open market or private purchase
$273,900 $16.5 p/Share
16,600 Added 1.03%
1,597,695 Common Stock, $0.0075 ...
Sep 16 2022
BUY
Open market or private purchase
$434,602 $17.89 p/Share
24,293 Added 1.35%
1,773,780 Common Stock, $0.0075 ...
Sep 15 2022
BUY
Open market or private purchase
$100,127 $17.96 p/Share
5,575 Added 0.35%
1,576,913 Common Stock, $0.0075 ...
Sep 14 2022
BUY
Open market or private purchase
$456,107 $17.25 p/Share
26,441 Added 1.65%
1,571,338 Common Stock, $0.0075 ...
Mar 31 2021
SELL
Open market or private sale
$21,857,413 $38.36 p/Share
569,797 Reduced 88.33%
75,287 Common Stock, $0.0075 ...
Sep 23 2020
BUY
Open market or private purchase
$311,020 $18.2 p/Share
17,089 Added 0.97%
1,750,704 Common Stock, $0.0075 ...
Sep 22 2020
BUY
Open market or private purchase
$220,496 $18.45 p/Share
11,951 Added 0.68%
1,743,503 Common Stock, $0.0075 ...
Sep 21 2020
BUY
Open market or private purchase
$410,612 $18.39 p/Share
22,328 Added 1.27%
1,738,512 Common Stock, $0.0075 ...
Sep 04 2020
BUY
Open market or private purchase
$145,223 $18.77 p/Share
7,737 Added 0.45%
1,728,443 Common Stock, $0.0075 ...
Sep 01 2020
BUY
Open market or private purchase
$331,584 $18.87 p/Share
17,572 Added 1.01%
1,724,613 Common Stock, $0.0075 ...
Aug 31 2020
BUY
Open market or private purchase
$295,772 $18.48 p/Share
16,005 Added 0.92%
1,716,941 Common Stock, $0.0075 ...
Aug 28 2020
BUY
Open market or private purchase
$39,183 $19.17 p/Share
2,044 Added 0.12%
1,710,079 Common Stock, $0.0075 ...
Aug 25 2020
BUY
Open market or private purchase
$112,318 $19.75 p/Share
5,687 Added 0.33%
1,709,157 Common Stock, $0.0075 ...
Aug 24 2020
BUY
Open market or private purchase
$225,599 $19.31 p/Share
11,683 Added 0.68%
1,706,913 Common Stock, $0.0075 ...
Aug 21 2020
BUY
Open market or private purchase
$208,753 $19.32 p/Share
10,805 Added 0.63%
1,701,734 Common Stock, $0.0075 ...
Aug 20 2020
BUY
Open market or private purchase
$33,881 $19.12 p/Share
1,772 Added 0.09%
1,967,800 Common Stock, $0.0075 ...
Aug 19 2020
BUY
Open market or private purchase
$68,871 $19.7 p/Share
3,496 Added 0.18%
1,966,028 Common Stock, $0.0075 ...
Aug 18 2020
BUY
Open market or private purchase
$17,247 $19.27 p/Share
895 Added 0.05%
1,962,532 Common Stock, $0.0075 ...
Aug 14 2020
BUY
Open market or private purchase
$409,722 $18.69 p/Share
21,922 Added 1.11%
1,961,637 Common Stock, $0.0075 ...
Aug 13 2020
BUY
Open market or private purchase
$18,690 $17.8 p/Share
1,050 Added 0.05%
1,939,715 Common Stock, $0.0075 ...
Aug 12 2020
BUY
Open market or private purchase
$70,227 $17.34 p/Share
4,050 Added 0.21%
1,938,665 Common Stock, $0.0075 ...

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CTIC
CTI BIOPHARMA CORP Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
> 10% Shareholder
ARQL
ARQULE INC
> 10% Shareholder
SNDX
Syndax Pharmaceuticals Inc Healthcare
> 10% Shareholder
IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
GLYC
GLYCOMIMETICS INC Healthcare
> 10% Shareholder
FPRX
FIVE PRIME THERAPEUTICS, INC.
CALA
Calithera Biosciences, Inc. Healthcare
> 10% Shareholder
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
> 10% Shareholder
KYMR
Kymera Therapeutics, Inc. Healthcare
Director
OLMA
Olema Pharmaceuticals, Inc. Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
RAIN
Rain Therapeutics Inc. Healthcare
Director
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
> 10% Shareholder
THRD
Third Harmonic Bio, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
> 10% Shareholder
MLTX
MoonLake Immunotherapeutics Healthcare
Director
PNT
POINT Biopharma Global Inc. Healthcare
BPL

Bvf Partners L P

Director
San Francisco, CA

Track Institutional and Insider Activities on XOMA

Follow XOMA Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XOMA shares.

Notify only if

Insider Trading

Get notified when an Xoma Corp insider buys or sells XOMA shares.

Notify only if

News

Receive news related to XOMA Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XOMA